Media coverage
1
Media coverage
Title Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment; Groundbreaking preclinical research highlights therapeutic potential of targeting the mechanical barrier in treat Media name/outlet Business Wire Country/Territory United States Date 11/3/21 Persons Rong Li